Cardiovascular · Inflammation
Aspirin COX‑1 / TXB₂ / Resolvin QSP
ASA PK to irreversible COX‑1 acetylation, TXB₂ turnover and aspirin-triggered resolvin branch.
Model description
ASA PK to irreversible COX‑1 acetylation, TXB₂ turnover and aspirin-triggered resolvin branch.
What can be done with this model
- ASA PK and salicylate handling
- Irreversible COX‑1 acetylation and platelet turnover
- TXB₂ inhibition and AT‑RvD1 extension
Free/open layer
- Draft model card and diagrams
Subscription layer
- Formulation PK/PD and DDI simulations
Downloads and artefacts
No public SBML download has been cleared yet. This page provides the model description and access boundary.